CapWealth Advisors’s Sanofi SNY Stock Holding History

CapWealth Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25	Closed	-$1K	–	234
2016 Q3	$1K	Buy	+25	New	+$1K	﹤0.01%	286
2014 Q2	–	Sell	-150	Closed	-$8K	–	384
2014 Q1	$8K	Hold	150	–	–	﹤0.01%	269
2013 Q4	$8K	Hold	150	–	–	﹤0.01%	275
2013 Q3	$8K	Hold	150	–	–	﹤0.01%	325
2013 Q2	$8K	Buy	+150	New	+$7.99K	﹤0.01%	308

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CapWealth Advisors's SNY Position: Q4 2016 in Review

CapWealth Advisors sold out of Sanofi (SNY) in Q4 2016, closing a stake of 25 shares — an estimated $1K sold.

CapWealth Advisors first reported a position in SNY in Q2 2013 and held it in 5 quarters. The position peaked at $8K in Q1 2014. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

CapWealth Advisors reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
CapWealth Advisors sold 25 Sanofi shares in Q4 2016, an estimated $1K.
CapWealth Advisors first reported a position in Sanofi in Q2 2013 and held it in 5 quarters.
CapWealth Advisors's Sanofi position peaked at $8K in Q1 2014.
476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on CapWealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.